PharmChain: A Blockchain-based Pharmaceutical Supply Chain Tracking System

The manufacturing and distribution of counterfeit tablets, especially in developing countries, is an urgent and increasingly critical global problem. Falsified medicinal products may contain incorrect ingredients and doses. One of the reasons for drug counterfeiting is the imperfect supply chain system in the pharmaceutical industry. Medicinal products are moved between manufacturers, suppliers, wholesalers, retailers, and pharmaceutical firms before meeting consumers. This study proposes PharmChain, a scenario-oriented drug traceability and regulation blockchain framework that reconstructs the entire service infrastructure by splitting the service provider into three separate service components and ensuring the authenticity and privacy of traceability details. PharmChain can track medication development via patient supply in the pharmaceutical industry. An Ethereum-based blockchain stores the transactions, and only trusted parties can access the data through the chain. We create and test our smart contract code in the Remix environment. We present detailed cost and security analyses incurred by supply chain stakeholders. We also use cost analysis to assess the performance of the proposed solution and demonstrate its affordability.

Authors

Publication Details

Journal
NECTAR - Northampton Electronic Collection of Thesis and Research (University of Northampton)
Published
2025-12-01
Primary Topic
Blockchain Technology Applications and Security
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PharmChain: A Blockchain-based Pharmaceutical Supply Chain Tracking System

Tatiana Gherman, Vincent Charles, N Chaudhary, Vijayant Pawar et al.
NECTAR - Northampton Electronic Collection of Thesis and Research (University of Northampton)
Blockchain Technology Applications and Security
article

PharmChain: A Blockchain-based Pharmaceutical Supply Chain Tracking System

Tatiana Gherman, Vincent Charles, N Chaudhary, Vijayant Pawar, Amrendra Singh Yadav, Vinay Kumar
article en

Abstract

The manufacturing and distribution of counterfeit tablets, especially in developing countries, is an urgent and increasingly critical global problem. Falsified medicinal products may contain incorrect ingredients and doses. One of the reasons for drug counterfeiting is the imperfect supply chain system in the pharmaceutical industry. Medicinal products are moved between manufacturers, suppliers, wholesalers, retailers, and pharmaceutical firms before meeting consumers. This study proposes PharmChain, a scenario-oriented drug traceability and regulation blockchain framework that reconstructs the entire service infrastructure by splitting the service provider into three separate service components and ensuring the authenticity and privacy of traceability details. PharmChain can track medication development via patient supply in the pharmaceutical industry. An Ethereum-based blockchain stores the transactions, and only trusted parties can access the data through the chain. We create and test our smart contract code in the Remix environment. We present detailed cost and security analyses incurred by supply chain stakeholders. We also use cost analysis to assess the performance of the proposed solution and demonstrate its affordability.

NECTAR - Northampton Electronic Collection of Thesis and Research (University of Northampton)
Industry, innovation and infrastructure
Openalex Percentile: Top 12%
Blockchain Technology Applications and Security
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.